对于可切除黑色素瘤的新辅助疗法
Cimarron E Sharon1, Giorgos C Karakousis2
1Department of Surgery, Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Maloney 4 3400 Spruce Street, Philadelphia, PA, 19104, USA. cimarron.sharon@pennmedicine.upenn.edu.
Clinical & experimental metastasis
|January 28, 2024
概括
与单独辅助治疗相比,治疗III/IV阶段黑色素瘤的新辅助治疗显示出患者反应的改善和毒性降低. 进一步的研究将根据患者对新辅助疗法的反应来个性化治疗计划.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床试验 临床试验
背景情况:
- 可切除的III/IV阶段黑色素瘤的标准治疗包括手术,然后再进行辅助治疗.
- 最近的进展为黑色素瘤患者的新辅助使用引入了全身疗法.
研究的目的:
- 对可切除III/IV期黑色素瘤的新辅助疗法的临床试验进行审查.
- 确定最佳的新辅助治疗方案,以最大限度地提高患者的反应并最大限度地降低毒性.
主要方法:
- 对调查黑色素瘤新辅助疗法的临床试验的系统审查.
- 对治疗结果,患者反应率和毒性概况的分析.
主要成果:
- 新辅助疗法在可切除的III/IV阶段黑色素瘤中比单独辅助疗法具有优势.
- 确定了最佳治疗方案,提高了患者的反应,减少了与治疗相关的毒性.
结论:
- 新辅助疗法是治疗可切除的III/IV阶段黑色素瘤的一个有前途的方法.
- 未来的研究应该专注于利用对新辅助治疗的反应来预后和个性化治疗计划.
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
01:30Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K